{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T05:22:21Z","timestamp":1733548941661,"version":"3.30.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.xcrm.2022.100843","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T15:38:04Z","timestamp":1670427484000},"page":"100843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A genetically engineered, stem-cell-derived cellular vaccine"],"prefix":"10.1016","volume":"3","author":[{"given":"Amanda","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Sidaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abishek","family":"Chandrashekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Latta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnendu","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Giffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordelia","family":"Manickam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Mosher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Keith","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rihab","family":"Gam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Arthofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Modassir","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Henley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100843_bib1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib3","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib4","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 covid-19 vaccine over 6\u00a0months","volume":"385","author":"Levin","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib5","doi-asserted-by":"crossref","first-page":"100208","DOI":"10.1016\/j.lanepe.2021.100208","article-title":"Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study","volume":"10","author":"Naaber","year":"2021","journal-title":"Lancet Reg. Health. Eur."},{"key":"10.1016\/j.xcrm.2022.100843_bib6","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6\u00a0months","volume":"385","author":"Thomas","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.abm0620","article-title":"SARS-CoV-2 vaccine protection and deaths among US veterans during 2021","volume":"375","author":"Cohn","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100843_bib8","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMc2115596","article-title":"Differential kinetics of immune responses elicited by covid-19 vaccines","volume":"385","author":"Collier","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc2108829","article-title":"Durable humoral and cellular immune responses 8 Months after Ad26.COV2.S vaccination","volume":"385","author":"Barouch","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/d41586-021-03552-w","article-title":"Heavily mutated Omicron variant puts scientists on alert","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib12","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S2666-7568(21)00230-0","article-title":"Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France","volume":"2","author":"Lef\u00e8vre","year":"2021","journal-title":"Lancet. Healthy Longev."},{"key":"10.1016\/j.xcrm.2022.100843_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the BNT162b2 covid-19 vaccine against the B.1.1.7 and B.1.351 variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib14","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.jaip.2020.04.045","article-title":"Commonly used adjuvant human vaccines: advantages and side effects","volume":"8","author":"Villarreal","year":"2020","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.xcrm.2022.100843_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00298-16","article-title":"Multivalent and multipathogen viral vector vaccines","volume":"24","author":"Lauer","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006904","article-title":"Polyvalent vaccines: high-maintenance heroes","volume":"14","author":"Schlingmann","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2022.100843_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2022.100843_bib18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2022.100843_bib19","doi-asserted-by":"crossref","first-page":"104842","DOI":"10.1016\/j.micpath.2021.104842","article-title":"Immunogenicity of HspX\/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model","volume":"154","author":"Yousefi Avarvand","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.xcrm.2022.100843_bib20","article-title":"Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma","volume":"8","author":"Cebon","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2022.100843_bib21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1099\/jmm.0.040857-0","article-title":"ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases","volume":"61","author":"Baz Morelli","year":"2012","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.xcrm.2022.100843_bib22","doi-asserted-by":"crossref","first-page":"101426","DOI":"10.1016\/j.smim.2020.101426","article-title":"The continued advance of vaccine adjuvants - 'we can work it out","volume":"50","author":"O'Hagan","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib23","doi-asserted-by":"crossref","first-page":"747774","DOI":"10.3389\/fimmu.2021.747774","article-title":"Matrix M adjuvanted H5N1 vaccine elicits broadly neutralizing antibodies and neuraminidase inhibiting antibodies in humans that correlate with in\u00a0vivo protection","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.vaccine.2016.02.033","article-title":"Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola\/Makona virus glycoprotein (GP) nanoparticle vaccine in mice","volume":"34","author":"Bengtsson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2022.100843_bib25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajem.2021.05.054","article-title":"Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines","volume":"49","author":"Long","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejim.2021.05.031","article-title":"Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines","volume":"89","author":"Cattaneo","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib28","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/mtm.2016.30","article-title":"Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens","volume":"3","author":"Afkhami","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2022.100843_bib29","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib30","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.lanepe.2021.100278","article-title":"Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: results from a nationwide case-control study in France","volume":"13","author":"Grant","year":"2022","journal-title":"Lancet Reg. Health. Eur."},{"key":"10.1016\/j.xcrm.2022.100843_bib31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.15585\/mmwr.mm7034e4","article-title":"Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (Delta) variant predominance - eight U.S. Locations, December 2020-August 2021","volume":"70","author":"Fowlkes","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.xcrm.2022.100843_bib32","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0213","article-title":"Pluripotent stem cells: induction and self-renewal","volume":"373","author":"Abu-Dawud","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.xcrm.2022.100843_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41536-020-00100-4","article-title":"Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis","volume":"5","author":"Deinsberger","year":"2020","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2022.100843_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib36","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2022.100843_bib37","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","author":"Wrapp","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2022.100843_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2017.00909","article-title":"Anti-inflammatory mechanisms triggered by apoptotic cells during their clearance","volume":"8","author":"Szondy","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000324176","article-title":"Natural killer cell responses to viral infection","volume":"3","author":"Brandstadter","year":"2011","journal-title":"J.\u00a0Innate Immun."},{"key":"10.1016\/j.xcrm.2022.100843_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coviro.2015.10.008","article-title":"Roles of natural killer cells in antiviral immunity","volume":"16","author":"Waggoner","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2022.100843_bib41","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3389\/fimmu.2019.01158","article-title":"Downregulation of MHC class I expression by influenza A and B viruses","volume":"10","author":"Koutsakos","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2016.02.007","article-title":"Recent advances in viral evasion of the MHC Class I processing pathway","volume":"40","author":"Schuren","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","article-title":"The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy","volume":"8","author":"Paul","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2018.00441","article-title":"NKG2D: a master regulator of immune cell responsiveness","volume":"9","author":"Wensveen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/7651_2015_203","article-title":"Induced pluripotent stem (iPS) cell culture methods and induction of differentiation into endothelial cells","volume":"1357","author":"Chatterjee","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2022.100843_bib46","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1002\/cpsc.117","article-title":"Human-induced pluripotent stem cell culture methods under cGMP conditions","volume":"54","author":"Rivera","year":"2020","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.xcrm.2022.100843_bib47","doi-asserted-by":"crossref","first-page":"21950","DOI":"10.1038\/s41598-020-78932-9","article-title":"Identification of potential transcription factors that enhance human iPSC generation","volume":"10","author":"Swaidan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100843_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/scrt39","article-title":"Role of Oct4 in maintaining and regaining stem cell pluripotency","volume":"1","author":"Shi","year":"2010","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.xcrm.2022.100843_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib51","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100843_bib52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100843_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100843_bib55","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100843_bib56","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/jmv.27516","article-title":"Sequence analysis of the emerging sars-CoV-2 variant omicron in South Africa","volume":"94","author":"Wang","year":"2022","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.xcrm.2022.100843_bib57","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.15585\/mmwr.mm7050e1","article-title":"SARS-CoV-2 B.1.1.529 (omicron) variant - United States, December 1-8, 2021","volume":"70","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.xcrm.2022.100843_bib58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2022.100843_bib59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100843_bib60","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6\u00a0months in a large integrated health system in the USA: a retrospective cohort study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2022.100843_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2021.01.073","article-title":"The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients","volume":"543","author":"Smits","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2022.100843_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00404-21","article-title":"Correlates of neutralization against SARS-CoV-2 variants of concern by early pandemic sera","volume":"95","author":"Vidal","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2022.100843_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108666","article-title":"The immunodominant and neutralization linear epitopes for SARS-CoV-2","volume":"34","author":"Lu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100843_bib64","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 Omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122004074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122004074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T01:23:01Z","timestamp":1733534581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122004074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2666379122004074"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100843","relation":{},"ISSN":["2666-3791"],"issn-type":[{"type":"print","value":"2666-3791"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A genetically engineered, stem-cell-derived cellular vaccine","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100843"}}